These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 11044775

  • 1. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
    Rogers SL, Doody RS, Mohs RC, Friedhoff LT.
    Arch Intern Med; 1998 May 11; 158(9):1021-31. PubMed ID: 9588436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group.
    Stroke; 2003 Oct 11; 34(10):2323-30. PubMed ID: 12970516
    [Abstract] [Full Text] [Related]

  • 7. Donepezil for dementia due to Alzheimer's disease.
    Birks JS, Harvey RJ.
    Cochrane Database Syst Rev; 2018 Jun 18; 6(6):CD001190. PubMed ID: 29923184
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
    Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S, Donepezil 401 Study Group.
    Neurology; 2004 Aug 24; 63(4):651-7. PubMed ID: 15326237
    [Abstract] [Full Text] [Related]

  • 9. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.
    Neurology; 2009 May 05; 72(18):1555-61. PubMed ID: 19176895
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
    Rogers SL.
    Dement Geriatr Cogn Disord; 1998 May 05; 9 Suppl 3():29-42. PubMed ID: 9853200
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R, 322 Study Group.
    Drugs Aging; 2004 May 05; 21(1):43-53. PubMed ID: 14715043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    Homma A, Atarashi H, Kubota N, Nakai K, Takase T.
    J Alzheimers Dis; 2016 Mar 11; 52(1):345-57. PubMed ID: 26967222
    [Abstract] [Full Text] [Related]

  • 18. Donepezil for dementia due to Alzheimer's disease.
    Birks JS, Harvey R.
    Cochrane Database Syst Rev; 2003 Mar 11; (3):CD001190. PubMed ID: 12917900
    [Abstract] [Full Text] [Related]

  • 19. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R, AWARE Study Group.
    CNS Drugs; 2006 Mar 11; 20(4):311-25. PubMed ID: 16599649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.